Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: A report by the cintredekin besudotox intraparenchymal study group Academic Article uri icon

Overview

MeSH Major

  • Drug Delivery Systems
  • Exotoxins
  • Glioma
  • Immunotoxins
  • Interleukin-13
  • Supratentorial Neoplasms

abstract

  • CB appears to have a favorable risk-benefit profile. CED is a complex delivery method requiring catheter placement via a second procedure to achieve accurate catheter positioning, better drug distribution, and better outcome.

publication date

  • March 2007

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2006.08.1117

PubMed ID

  • 17327604

Additional Document Info

start page

  • 837

end page

  • 44

volume

  • 25

number

  • 7